Genetic Immunity is a US clinical-stage biotechnology company focusing on the discovery, development and commercialization of a new class of therapeutic vaccines ("Immune Therapies") for the treatment of chronic viral infections (HIV, HPV), cancer and allergies. Our Immune Therapies are designed to intensify and boost specific immune response to modify or control these presently incurable diseases. We believe our products will allow people to live better, healthier and longer lives.
We are a Phase II therapeutic vaccine company with a lead product candidate for the treatment of HIV. This is our Initial Coin Offering feed.
More ICO's starting today!
CryptoFlix - 9.16 - @Crypto_Flix
Dermavir - 9.09 - @DermavirICO/
QYKBAR - 9.01 - @QYKBARx
Moneda - 8.87 - https://buff.ly/2wIdxWN
DirectHome - 8.83 - @DirectHomeICO
#ico #initialcoinoffering #cryptocurrency #token #blockchain #tokensale #altcoins
Our Initial Coin Offering is now LIVE. A total of 10,000,000 tokens are available at a per token price of $1.00. Help us bring an HIV vaccine to market. Visit https://www.dermavir.com to participate. #HIV #ICO @IanScarffe @DavidDrakeVC @SimonCocking
Thank you for sharing our ICO.
When it comes to #ICO’s I’ve been very intrigued by the #healthcare ones. One very interesting one @DermavirICO is developing immune therapies for infections such as HIV and HPV. Read more about their #blockchain project at http://www.dermavir.com #crypto
Thank you for including @DermavirICO
Yet more healthcare ICOs added to the list:
Current list count = 108
Our 3rd presale is now LIVE. DER tokens are available at $0.90 per token with a total supply of 3,000,000. Visit https://www.dermavir.com to participate. @SimonCocking @IanScarffe @DavidDrakeVC #HIV #Crypto
|Price||1.00 USD||Sale||10,000,000||Payment Mode||ETH|
|Minimum Investment||0.1 ETH||Distribution||50%||Raised||Unknown|
|Soft Cap||N/A||Hard Cap||10 000 000 DER|